Proven for weeks and still live — safe to model.
Battle-tested: running 57 days across 2 GEOs. Surviving this long usually means it's profitable enough to keep funding.
Seen across United Kingdom/United States — the angle travels across these markets.
- Seen 57/30 days
- 2 GEOs
- Redirect chain checked
- LP host: carefndr.com
Reverse-engineered from the live ad — longevity, GEOs, and the affiliate funnel behind it. Verified by following the redirect chain on Jun 12. Free, no login.
Funnel, reverse-engineered
The campaign behind this creative
← the actual path the money takes.
Creative
Carcinoid Syndrome Study
Landing page
carefndr.com
where it lands
Product / Offer
not detected
Tracker
not detected
Affiliate network
not detected
How we know: the tracker and affiliate network come from the live redirect chain we followed and fingerprinted hop by hop. Greyed nodes weren’t detected.
Sustained high-scale signal
running 57d · seen today · 2 markets
Observed at high scale and still active for 57d — a strong, long-running signal worth modelling (no spend/CTR data; scale is inferred from observation volume).
Gravity
53/100
push pressure now · 30d index
Strength
64/100
overall scale · 30d index
Run
57d
last seen Today
Markets
2
countries seen
Landing page
carefndr.com
final host
Screenshot
—
not captured yet
Operator
—
unidentified
Network
Taboola
traffic source
Join a Carcinoid Syndrome Study
Carcinoid Syndrome Study@carcinoid
Caring for someone with carcinoid syndrome? This study may be an option.
Top 10% longevity in network
Days alive is a profitability proxy — advertisers don’t pay to run losers.
Geo reach
Regional push2 marketsPredominantly Tier 1, concentrated in North America — United Kingdom, United States.
What the data shows
Carcinoid Syndrome Study's Taboola creative has been running for 57 days across 2 countries and first seen on April 15, 2026 and last seen on June 12, 2026. It has been observed in United Kingdom and United States. The ad lands on carefndr.com. On our 30-day observation series the creative has run in sharp traffic spikes over the last 30 days. Carcinoid Syndrome Study is running 5 other creatives we have indexed, linked below for side-by-side comparison.
Creative headline: Join a Carcinoid Syndrome Study. Indexed on Taboola by mediabuyer.
Landing-page intelligence
Landing page intelligence
Where this ad lands
The lander is the product — screenshot, redirect chain, offer, tech stack, and on-page text in one place.
Landing page not captured yet
Our crawler renders each advertiser’s funnel on a rolling schedule. Recently observed ads are queued first — check back to see the full-page screenshot.
Redirect chain
Chain not captured yet.
Final host: carefndr.com. Hop-by-hop capture runs as a separate pipeline; ads observed in recent ingests get crawled first.
Tracking parameters
No query string on this URL.
Tracking setup · Taboola
Taboola passes site, site_id, campaign_id, campaign_item_id and click-id by default. Map those to your tracker's source/sub1-4 fields. Use {click_id} as your unique click identifier when posting back conversions.
?site={site}&site_id={site_id}&campaign_id={campaign_id}&campaign_item_id={campaign_item_id}&click-id={click_id}Default Taboola setup template: ?site={site}&site_id={site_id}&campaign_id={campaign_id}&campaign_item_id={campaign_item_id}&click-id={click_id}
Tech stack
No third-party monetization stack detected — this appears to be a direct landing page.
Landing page hubs
Landing page text
On-page text not extracted yet.
Observed daily (last 30 days)
Apr 25 → May 24·peaks May 21
30-day run pattern
SpikyHeavy traffic bursts on a few days with quieter days in between — typical of aggressive A/B testing or geo/daypart targeting.
- Coverage
- 67% of 30d
- Peak surge
- 4× vs median
- Last 7d
- 28
- WoW
- +155%
Peak day: — 4× the median day, indicating a deliberate budget push.
Window: Apr 25 → May 24
Sibling creatives from this campaign
Other creatives in Other on Taboola
The rest of the set they’re running — see what else this angle is paired with.
Tested headline variants5
Tested headline variants
Carcinoid Syndrome Study's own A/B test — which headline they kept
The advertiser’s own A/B result, handed over: ranked by days running, the survivor on top. Variants they stopped running are struck through — they tested and killed those angles.
- #1Carcinoid Syndrome Study58d3 content tokens
- #2Neuroendocrine Tumors Trial. Learn More58d4 content tokens
- #3Be Part of CS Research. Join a Clinical Study58d6 content tokens
- #4Carcinoid Syndrome Clinical Trial58d4 content tokens
More from Carcinoid Syndrome Study5
More from Carcinoid Syndrome Study
Carcinoid Syndrome Clinical Trial | Crinetics What is carcinoid syndrome? What…
carefndr.comMost spy tools stop at the creative. This page connects it to the campaign behind it — the funnel, the longevity, the GEOs. Free.